ANI Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $31.1M | $27.4M | $154.7M | $169.0M | $11.1M | $11.0K | $0 | $38.2M |
| Accounts Receivable | $58.8M | $45.9M | $21.9M | $17.3M | $12.5M | $5.4M | — | — |
| Inventory | $37.7M | $26.2M | $13.4M | $7.5M | $3.5M | $2.8M | — | — |
| Total Current Assets | $131.6M | $103.0M | $192.6M | $195.0M | $27.7M | $8.6M | $58.0M | $40.6M |
| Property, Plant & Equipment | $20.4M | $11.0M | $7.1M | $5.2M | $4.5M | $4.9M | $861.4K | $635.8K |
| Goodwill | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $0 | — | — |
| Intangible Assets (Excl. Goodwill) | $229.8M | $175.8M | $66.4M | $42.1M | $10.4M | $85.0K | — | — |
| Total Assets | $412.1M | $322.9M | $285.3M | $259.6M | $44.5M | $13.7M | $62.4M | $44.8M |
| Liabilities | ||||||||
| Accounts Payable | $3.6M | $3.4M | $2.1M | $2.7M | $1.4M | $2.0M | $3.2M | $4.9M |
| Total Current Liabilities | $39.2M | $31.9M | $11.8M | $13.2M | $3.5M | $7.7M | $7.2M | $8.2M |
| Long-Term Debt | $69.9M | $0 | $113.4M | $106.5M | — | — | — | — |
| Total Liabilities | $237.4M | $153.2M | $125.2M | $119.8M | $3.5M | $10.6M | $24.6M | $25.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-4.0M | $-2.9M | $-4.4M | $-19.7M | $-48.5M | $-43.8M | $-217.2M | $-165.6M |
| Total Stockholders' Equity | $174.8M | $169.6M | $160.1M | $139.8M | $41.0M | $-42.7M | $-34.3M | $19.1M |